Skip to main content

Peer Review reports

From: Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatment

Original Submission
15 Jul 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
25 Nov 2021 Reviewed Reviewer Report
22 Jan 2022 Reviewed Reviewer Report
17 Feb 2022 Author responded Author comments - Jae Hee Cheon
Resubmission - Version 5
17 Feb 2022 Submitted Manuscript version 5
26 Feb 2022 Author responded Author comments - Jae Hee Cheon
Resubmission - Version 6
26 Feb 2022 Submitted Manuscript version 6
3 Mar 2022 Author responded Author comments - Jae Hee Cheon
Resubmission - Version 7
3 Mar 2022 Submitted Manuscript version 7
11 Mar 2022 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
15 Mar 2022 Editorially accepted
27 Mar 2022 Article published 10.1186/s12876-022-02225-w

You can find further information about peer review here.

Back to article page